Track the Apollomics Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €50.2m. The latest transaction was filed on 17 August 2026 (Acquisition). Among the most active insiders: Chen Hung-Wen. Every trade is accessible without an account.
14
Insider Decl.
n/a
Thresholds
€7m
5 ops.
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
Buys €7mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,582 shares@ US$15.85100.0% of flowCLASS A ORDINARY SHARESSEC:0001193125-26-161997:0
14 of 14 declarations
About Apollomics Inc.
Apollomics Inc. is a biopharmaceutical company focused on developing innovative treatments for cancer. It is listed on the NASDAQ under the ticker APLM.